ORLY vs TCRX · P/E 34, rev $17.78B vs rev $2.0M
O’Reilly Automotive Inc (ORLY) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported ORLY revenue for 2025-12-31 was $17.78B. Net income was $2.54B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
ORLY currently screens at market cap $78.32B and trailing P/E 33.7. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the ORLY and TCRX stock pages for the full models.
Not investment advice.